BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30394113)

  • 21. Cytotoxic Effects on Breast Cancer Cell Lines of Chalcones Derived from a Natural Precursor and Their Molecular Docking Analysis.
    Bustos L; Echiburú-Chau C; Castro-Alvarez A; Bradshaw B; Simirgiotis MJ; Mellado M; Parra C; Cuellar M
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
    Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
    Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC
    Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
    Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
    Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
    Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
    Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
    Ethiraj KR; Aranjani JM; Khan FR
    Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
    Mohamed MF; Hassaneen HM; Abdelhamid IA
    Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
    Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Thienyl-4-furyl-6-aryl pyridine derivatives: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
    Thapa P; Karki R; Thapa U; Jahng Y; Jung MJ; Nam JM; Na Y; Kwon Y; Lee ES
    Bioorg Med Chem; 2010 Jan; 18(1):377-86. PubMed ID: 19939682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways.
    Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ
    Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization.
    Mohammed HHH; Abd El-Hafeez AA; Ebeid K; Mekkawy AI; Abourehab MAS; Wafa EI; Alhaj-Suliman SO; Salem AK; Ghosh P; Abuo-Rahma GEA; Hayallah AM; Abbas SH
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1346-1363. PubMed ID: 35548854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[
    Mphahlele MJ; Maluleka MM; Parbhoo N; Malindisa ST
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.
    Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q
    Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors.
    Sangpheak K; Tabtimmai L; Seetaha S; Rungnim C; Chavasiri W; Wolschann P; Choowongkomon K; Rungrotmongkol T
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30897725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents.
    Thapa P; Jun KY; Kadayat TM; Park C; Zheng Z; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES
    Bioorg Med Chem; 2015 Oct; 23(19):6454-66. PubMed ID: 26361737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
    Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imidazopyridine chalcones as potent anticancer agents: Synthesis, single-crystal X-ray, docking, DFT and SAR studies.
    Soumyashree DK; Reddy DS; Nagarajaiah H; Naik L; Savanur HM; Shilpa CD; Sunitha Kumari M; Shanavaz H; Padmashali B
    Arch Pharm (Weinheim); 2023 Jul; 356(7):e2300106. PubMed ID: 37208792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
    Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
    Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.